Cherie P Erkmen, Ryan F Moore, Clifford Belden, Verdi DiSesa, Larry R Kaiser, Grace X Ma, Anuradha Paranjape
{"title":"通过实施单次就诊患者体验克服肺癌筛查障碍。","authors":"Cherie P Erkmen, Ryan F Moore, Clifford Belden, Verdi DiSesa, Larry R Kaiser, Grace X Ma, Anuradha Paranjape","doi":"10.15436/2377-0902.17.1469","DOIUrl":null,"url":null,"abstract":"In 2011 the authors of the National Lung Screening Trial (NLST) reported a 20% risk reduction of lung cancer death using annual screening with a low dose CT (LDCT)[1]. In 2013, the United States Preventative Services Task Force (USPSTF) gave lung cancer screening a grade B recommendation indicating that LDCT should be covered by private insurers without cost sharing (co-pay)[2]. Implementation of a screening program could potentially avert 12,000 deaths annually[3]. Unfortunately, implementation of lung cancer screening programs has been slower than expected. Despite evidence that USPSTF recommendations influence 88.4% of practicing primary care providers (PCP’s)[4], only 47% of PCPs acknowledged the lung cancer screening recommendation[5], and only 12% of PCPs in an academic setting used LDCT scan for lung cancer screening[6]. The reasons for the failure to generate enthusiasm to implement lung cancer screening are multifactorial. However, lung cancer screening provides an opportunity to design novel patient-centered care. In this discussion, we will explore both the barriers to lung cancer screening implementation and our multidisciplinary approach which prioritizes patient-centered care by creating a single-visit patient experience.","PeriodicalId":91089,"journal":{"name":"International journal of cancer and oncology","volume":"4 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796669/pdf/","citationCount":"8","resultStr":"{\"title\":\"Overcoming Barriers to Lung Cancer Screening by Implementing a Single-Visit Patient Experience.\",\"authors\":\"Cherie P Erkmen, Ryan F Moore, Clifford Belden, Verdi DiSesa, Larry R Kaiser, Grace X Ma, Anuradha Paranjape\",\"doi\":\"10.15436/2377-0902.17.1469\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In 2011 the authors of the National Lung Screening Trial (NLST) reported a 20% risk reduction of lung cancer death using annual screening with a low dose CT (LDCT)[1]. In 2013, the United States Preventative Services Task Force (USPSTF) gave lung cancer screening a grade B recommendation indicating that LDCT should be covered by private insurers without cost sharing (co-pay)[2]. Implementation of a screening program could potentially avert 12,000 deaths annually[3]. Unfortunately, implementation of lung cancer screening programs has been slower than expected. Despite evidence that USPSTF recommendations influence 88.4% of practicing primary care providers (PCP’s)[4], only 47% of PCPs acknowledged the lung cancer screening recommendation[5], and only 12% of PCPs in an academic setting used LDCT scan for lung cancer screening[6]. The reasons for the failure to generate enthusiasm to implement lung cancer screening are multifactorial. However, lung cancer screening provides an opportunity to design novel patient-centered care. In this discussion, we will explore both the barriers to lung cancer screening implementation and our multidisciplinary approach which prioritizes patient-centered care by creating a single-visit patient experience.\",\"PeriodicalId\":91089,\"journal\":{\"name\":\"International journal of cancer and oncology\",\"volume\":\"4 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796669/pdf/\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of cancer and oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15436/2377-0902.17.1469\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/5/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cancer and oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15436/2377-0902.17.1469","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/5/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Overcoming Barriers to Lung Cancer Screening by Implementing a Single-Visit Patient Experience.
In 2011 the authors of the National Lung Screening Trial (NLST) reported a 20% risk reduction of lung cancer death using annual screening with a low dose CT (LDCT)[1]. In 2013, the United States Preventative Services Task Force (USPSTF) gave lung cancer screening a grade B recommendation indicating that LDCT should be covered by private insurers without cost sharing (co-pay)[2]. Implementation of a screening program could potentially avert 12,000 deaths annually[3]. Unfortunately, implementation of lung cancer screening programs has been slower than expected. Despite evidence that USPSTF recommendations influence 88.4% of practicing primary care providers (PCP’s)[4], only 47% of PCPs acknowledged the lung cancer screening recommendation[5], and only 12% of PCPs in an academic setting used LDCT scan for lung cancer screening[6]. The reasons for the failure to generate enthusiasm to implement lung cancer screening are multifactorial. However, lung cancer screening provides an opportunity to design novel patient-centered care. In this discussion, we will explore both the barriers to lung cancer screening implementation and our multidisciplinary approach which prioritizes patient-centered care by creating a single-visit patient experience.